D3R on bone marrow-derived mast cells may negatively regulate LPS-induced TLR4 expression and its downstream production of TNF and other cytokines (38), thus effectively inhibiting the production of ROS and reducing joint inflammation in RA patients. This evidence concerns the gene TNF and rheumatoid arthritis.